RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Itamar Medical Stock

Itamar Medical Stocks 2024

Itamar Medical Stocks

415.44 M

Ticker

ITMR.TA

ISIN

IL0011024580

WKN

A1CZAF

In 2024, Itamar Medical had 415.44 M outstanding stocks, a 24.89% change from the 332.65 M stocks in the previous year.

The Itamar Medical Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2020415.44
2019332.65
2018277.67
2017264.11
2016262.54
2015191.81
2014174.87
2013137.38
2012150.95
2011143.93
2010165.68
2009121.11
2008120.21
2007100.24
2006119.74
2005119.74
2004119.74
2003119.74

Itamar Medical shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Itamar Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Itamar Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Itamar Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Itamar Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Itamar Medical Aktienanalyse

What does Itamar Medical do?

Itamar Medical Ltd is a company specialized in the development and marketing of non-invasive diagnostic and monitoring solutions for sleep disorders, heart diseases, and peripheral vascular diseases. The company was founded in Israel in 1997. The history of Itamar Medical begins with the development of the PAT system (Peripheral Arterial Tone), a device that uses the peripheral arterial tonometer to measure blood flow. With this system, doctors were able to record patients' sleep for the first time and diagnose sleep disorders such as obstructive sleep apnea syndrome (OSAS) or restless leg syndrome (RLS). Over the years, the company has expanded its offerings and developed various solutions to improve the diagnosis and monitoring of heart and vascular diseases. Itamar Medical's products now include the EndoPAT, WatchPAT, and Total Sleep Solution, among others. The EndoPAT is a non-invasive medical device that measures the endothelial function state of patients. This refers to the ability of blood vessels to dilate when needed to increase blood flow. The EndoPAT allows doctors to assess the cardiovascular health status of patients and predict the risk of cardiovascular diseases. The WatchPAT is a wearable sleep monitor that wirelessly connects to an app. The device records the sleep architecture of patients and automatically detects sleep apnea episodes, which are then displayed on the app. The WatchPAT enables doctors to improve the sleep quality of patients and diagnose sleep disorders. Itamar Medical's Total Sleep Solution offers a comprehensive solution for the management of sleep disorders. The solution includes the WatchPAT tracker, the PAT procedures for sleep disorder diagnosis, and the EndoPAT procedures for assessing cardiovascular health. This combination of technologies allows doctors to treat their patients holistically and improve their cardiovascular health and sleep quality. Itamar Medical has also formed partnerships with other companies to enhance its solutions and promote new developments. Currently, the company is collaborating with Teva Pharmaceutical Industries to develop a new formulation of Sildenafil, a medication used for treating erectile dysfunction. Overall, Itamar Medical has experienced strong growth in recent years. The company has branches in the USA, Europe, and Asia and is constantly working to expand its offerings and improve its technology for the diagnosis and monitoring of heart and sleep disorders. In summary, Itamar Medical is an innovative provider of non-invasive diagnostic and monitoring solutions for sleep disorders, heart diseases, and peripheral vascular diseases. With its wide range of products and partnerships with other companies, the company is well-positioned to continue growing and expanding in the coming years. Itamar Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Itamar Medical's Shares Outstanding

Itamar Medical's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Itamar Medical’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Itamar Medical’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Itamar Medical’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Itamar Medical stock

How many stocks are there of Itamar Medical?

The current number of stocks of Itamar Medical is 415.44 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Itamar Medical are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Itamar Medical evolved in recent years?

The number of shares of Itamar Medical has increased by 24.89% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Itamar Medical as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Itamar Medical?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Itamar Medical pay?

Over the past 12 months, Itamar Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Itamar Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Itamar Medical?

The current dividend yield of Itamar Medical is .

When does Itamar Medical pay dividends?

Itamar Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Itamar Medical?

Itamar Medical paid dividends every year for the past 0 years.

What is the dividend of Itamar Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Itamar Medical located?

Itamar Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Itamar Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Itamar Medical from 12/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.

When did Itamar Medical pay the last dividend?

The last dividend was paid out on 12/19/2024.

What was the dividend of Itamar Medical in the year 2023?

In the year 2023, Itamar Medical distributed 0 USD as dividends.

In which currency does Itamar Medical pay out the dividend?

The dividends of Itamar Medical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Itamar Medical

Our stock analysis for Itamar Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Itamar Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.